Desoximetasone Ointment USP — Class II drug recall D-0152-2017
Terminated recall by Akorn Inc, reported 2016-11-30, distributed nationwide. Failed Stability Specifications; out-of specification value for homogeneity / phase separation.
| Recall number | D-0152-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Akorn Inc, Lake Forest, IL, United States |
| Recall initiated | 2016-11-14 |
| Classified | 2016-11-23 |
| Reported by FDA | 2016-11-30 |
| Terminated | 2019-05-10 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 61748-0206-15, 61748-0206-60 |
| Lot numbers | 348716 |
| Expiration dates | 2017-12 |
Product
Desoximetasone Ointment USP, 0.25%, a) 15 g tubes (NDC 61748-206-15 and b) 60 g tubes (NDC 61748-206-60, Marketed by Versapharm Inc., An Akorn Company, Lake Forest, IL, Manufactured by Hi-Tech, Pharmacal Co, Inc., Amityville, NY
Reason for recall
Failed Stability Specifications; out-of specification value for homogeneity / phase separation.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0152-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.